The acute effects of magnesium in atrial fibrillation and flutter with a rapid ventricular rate
Authors:
- Steve WalkerSWSteve Walker
- James TaylorJTJames Taylor
- Richard HarrodRHRichard Harrod
- 1 December 1996
- journal article
- Published by Wiley in Emergency Medicine
- Vol. 8 (4) , 207-213
Abstract
A prospective, randomised, placebo controlled, double blinded trial to assess the efficacy of intravenous magnesium sulphate (20mmol over 30 minutes) versus placebo in patients presenting to the emergency department with rapid atrial fibrillation and flutter. The end points were slowing of the ventricular rate and reversion to sinus rhythm. A total of 41 patients were enrolled. The mean decrease in heart rate 30 minutes after commencing the infusion was 24.1/min for the magnesium group compared to 11.0/min for the placebo group (different at the 95% level of significance). The mean decrease in heart rate and the reversion rate four hours after commencing the infusion were the same at the 95% level of significance for the two groups. We conclude that magnesium has a significant effect in the acute slowing of ventricular rate but no effect in achieving reversion to sinus rhythm.Keywords
This publication has 30 references indexed in Scilit:
- The emergency department management of torsades de pointesEmergency Medicine, 1994
- Effect of Magnesium Sulfate on Ventricular Rate Control in Atrial FibrillationAnnals of Emergency Medicine, 1994
- Possible atrial proarrhythmic effects of class 1C antiarrhythmic drugsThe American Journal of Cardiology, 1990
- Effect of intravenous magnesium sulfate on supraventricular tachycardiaThe American Journal of Cardiology, 1989
- Electrophysiologic effects of intravenous magnesium in patients with normal conduction systems and no clinical evidence of significant cardiac diseaseAmerican Heart Journal, 1988
- Flecainide acetate for conversion of acute supraventricular tachycardia to sinus rhythmThe American Journal of Cardiology, 1987
- Magnesium and potassium therapy in multifocal atrial tachycardiaAmerican Heart Journal, 1985
- Magnesium therapy for torsades de pointesThe American Journal of Cardiology, 1984
- Calcium Antagonists Clinical Use in the Treatment of ArrhythmiasDrugs, 1983
- Effects of intravenous and chronic oral verapamil administration in patients with supraventricular tachyarrhythmias.Circulation, 1980